- Investing Ideas
- Belgian Large Cap High Growth Potential
Belgian Large Cap High Growth Potential
Results
6
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
6 companies
argenx
Market Cap: €42.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€700.80
7D
-2.3%
1Y
12.4%
Elia Group
Market Cap: €13.7b
Develops and operates as a transmission system operator in Belgium and Germany.
ELI
€130.00
7D
4.1%
1Y
105.4%
Groupe Bruxelles Lambert
Market Cap: €10.0b
Invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally.
GBLB
€83.25
7D
2.0%
1Y
23.0%
UCB
Market Cap: €50.2b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€264.00
7D
-0.9%
1Y
38.7%
Lotus Bakeries
Market Cap: €8.6b
Provides various snack products in Belgium and internationally.
LOTB
€10,720.00
7D
5.3%
1Y
17.8%
D'Ieteren Group
Market Cap: €10.5b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€196.80
7D
0.5%
1Y
23.2%